Dr. Qin Ning is a Professor in Hepatology and Clinical Immunology. She is the chair of the institute &Department of Infectious Diseases in Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology.
Dr. Ning is the Vice President, Chinese Society of Infectious Disease CMA; the Regional Council Member, International Association for the Study of Liver (IASL); Member for APASL ACLF Study Group and International Symposium on Viral Hepatitis and Liver Disease (ISVHLD) Global Hepatitis Summit (GHS); Executive Committee Member for Coalition to Eradicate Viral Hepatitis in Asia Pacific (CEVHAP)
Dr. Ning has published over 363 original papers internationally, including BMJ-British Medical Journal, J Clin Invest, J of Hepatology, J Biol Chem, J Immunol, Human Gene Therapy, Hepatology International, Liver International, Frontiers in Immunology,etc. These works have been cited more than 5706 times .
She also served as editors or reviewers for J Hepatology, Lance Gastroentology and Hepatology, Hepatology International, Human Gene Therapy et al.
Dr. Ning’s clinical care activities include hepatology, clinical immunology, and infectious disease, with focus on viral hepatitis, and recently emerging SARS-CoV-2 infected COVID-19.
The lecture video：0
Abstract：54
3294
0
0
The academic assignments are as follows
| Date (UTC+8) | Time (UTC+8) | Local Time | Room | Session | Role | Talk Title |
|---|---|---|---|---|---|---|
| 2022-09-16 | 09:00-09:30 | 2022-09-16,09:00-09:30 | Meeting Room 1 |
State-of-the-art Session 1 |
Speaker | Clinical and immunological features of COVID-19 : Implications for management |
| 2022-09-17 | 09:00-09:30 | 2022-09-17,09:00-09:30 | Meeting Room 1 |
State-of-the-art Session 2 |
Speaker | CCIFLDI meets APASL: A history of first golden ten years |
| 2022-09-17 | 13:45-14:05 | 2022-09-17,13:45-14:05 | Meeting Room 2 |
Concurrent Session 5 - Bacterial Infections in ESLD |
Speaker | Algorithm and Choice of Antibiotics in ACLF |
| 2022-09-17 | 15:30-17:00 | 2022-09-17,15:30-17:00 | Meeting Room 1 |
State-of-the-art Session 3 |
Moderator | |
| 2022-09-17 | 17:00-18:30 | 2022-09-17,17:00-18:30 | Meeting Room 1 |
Concurrent Session 7 - Drug Development for Liver Disease |
Moderator |